0000905718-14-000839.txt : 20141224 0000905718-14-000839.hdr.sgml : 20141224 20141224090829 ACCESSION NUMBER: 0000905718-14-000839 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20141224 DATE AS OF CHANGE: 20141224 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Regado Biosciences Inc CENTRAL INDEX KEY: 0001311596 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030422069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-87592 FILM NUMBER: 141308895 BUSINESS ADDRESS: STREET 1: 120 MOUNTAIN VIEW BOULEVARD CITY: BASKING RIDGE STATE: NJ ZIP: 00000 BUSINESS PHONE: 908.580.2111 MAIL ADDRESS: STREET 1: 120 MOUNTAIN VIEW BOULEVARD CITY: BASKING RIDGE STATE: NJ ZIP: 00000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KIERLIN ROBERT A CENTRAL INDEX KEY: 0000901066 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: FASTENAL CO 2001 THEURER BOULEVARD STREET 2: P O BOX 978 CITY: WINONA STATE: MN ZIP: 55987 SC 13G/A 1 kierlin_13gam1nov252014.htm AMENDMENT NO. 1

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

(Amendment No. 1)*

Under the Securities Exchange Act of 1934

Regado Biosciences, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

75874Q107

(CUSIP Number)

November 25, 2014

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:

[ ] Rule 13d-1(b)

[X] Rule 13d-1(c)

[ ] Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 75874Q107
(1)	Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only).
	Robert A. Kierlin
(2)	Check the Appropriate Box if a Member of a Group (See Instructions)			(a) [ ]
				(b) [ ]
	NOT APPLICABLE
(3)	SEC Use Only
(4)	Citizenship or Place of Organization:
	United States
Number of Shares Beneficially Owned By Each Reporting Person With
		(5) Sole Voting Power:	2,284,955
		(6) Shared Voting Power:	None
		(7) Sole Dispositive Power:	2,284,955
		(8) Shared Dispositive Power:	None

(9)	Aggregate Amount Beneficially Owned by Each Reporting Person:
	2,284,955
(10)	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions):
	NOT APPLICABLE
(11)	Percent of Class Represented by Amount in Row (9):
	6.8%
(12)	Type of Reporting Person (See Instructions):
	IN

CUSIP No. 75874Q107

Item 1.
	(a)		Name of Issuer: Regado Biosciences, Inc.
	(b)		Address of Issuer’s Principal Executive Offices:
			120 Mountain View Boulevard Basking Ridge, New Jersey 07920
Item 2(a). Name of Person Filing:
		Robert A. Kierlin
Item 2(b). Address of Principal Business Office or, if None, Residence:
		Robert A. Kierlin Fastenal Company 2001 Theurer Boulevard Winona, Minnesota 55987-1500
Item 2(c). Citizenship:
		Robert A. Kierlin is a citizen of the United States
Item 2(d). Title of Class of Securities:
		Common Stock, par value $0.001 per share
Item 2(e). CUSIP No.:
		75874Q107
Item 3. If This Statement Is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
		NOT APPLICABLE
Item 4. Ownership:
			(a)	Amount Beneficially Owned:		2,284,955
			(b)	Percent of Class:		6.8%
			(c)	Number of Shares as to which such person has:
					(i) Sole power to vote or to direct the vote:	2,284,955
					(ii) Shared power to vote or to direct the vote:	0
					(iii) Sole power to dispose or to direct the disposition of:	2,284,955
					(iv) Shared power to dispose or to direct the disposition of:	0

CUSIP No. 75874Q107

Item 5.	Ownership of Five Percent or Less of a Class:
	NOT APPLICABLE
Item 6.	Ownership of More Than Five Percent on Behalf of Another Person:
	NOT APPLICABLE
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:
	Not Applicable.
Item 8.	Identification and Classification of Members of the Group:
	NOT APPLICABLE
Item 9.	Notice of Dissolution of Group:
	NOT APPLICABLE
Item 10.	Certification:
	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

CUSIP No. 75874Q107

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

	December 24, 2014


	By:	/s/ Robert A. Kierlin
		Robert A. Kierlin

Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (See 18 U.S.C. 1001)